Almotriptan Malate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

14 API Suppliers, 6 USDMF, 1 CEP/COS, 5 EU WC, 4 NDC API, 8 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

25 FDF Dossiers, 8 FDA Orange Book, 11 Europe, 6 Canada

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 6.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 14 SPI Pharma, 2 Seqens, 2 DKSH, 3 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 10 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 3 Actylis, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 20 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 2 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 6 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 3 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 6 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 45 Fillers, Diluents & Binders, 29 Direct Compression, 28 Disintegrants & Superdisintegrants, 27 Controlled & Modified Release, 19 Thickeners and Stabilizers, 19 Granulation, 15 Co-Processed Excipients, 14 Chewable & Orodispersible Aids, 14 Solubilizers, 12 Taste Masking, 11 Film Formers & Plasticizers, 10 Topical, 10 Lubricants & Glidants, 9 Parenteral, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Rheology Modifiers, 2 Emulsifying Agents

DIGITAL CONTENT

2 NEWS #PharmaBuzz

2 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Finished Drug Prices

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 1 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21001 / DOSAGE - TABLET;ORAL - EQ 6.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
almotriptan malate(UNII: PJP312605E) (almotriptan - UNII:1O4XL5SN61)	almotriptan	12.5mg \| 6.25mg

Inactive Ingredients

Ingredient Name	Janssen Pharmaceuticals, Inc.	Patriot Pharmaceuticals, LLC
carnauba wax(R12CBM0EIZ)
FD&C Blue No. 2(L06K8R7DQK)
ferric oxide red(1K09F3G675)
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
mannitol(3OWL53L36A)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
POVIDONE, UNSPECIFIED(FZ989GH94E)
powdered cellulose(SMD1X3XO9M)
propylene glycol(6DC9Q167V3)
sodium starch glycolate type A potato(5856J3G2A2)
sodium stearyl fumarate(7CV7WJK4UI)
titanium dioxide(15FIX9V2JP)

Drug Product Composition: Almotriptan Malate